Insulin and glucagon signaling in the central nervous system

Reviews in Endocrine and Metabolic Disorders

Volumn 14, Issue 4, 2013, Pages 365-375

  Filippi, Beatrice M ^a,b   Abraham, Mona A ^a,b   Yue, Jessica T Y ^a,b   Lam, Tony K T ^a,b,c,d  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d MaRS Centre   (Canada)

Author keywords

Brain; Food intake; Glucagon; Glucose; Insulin

Indexed keywords

AGOUTI RELATED PROTEIN; GLUCAGON; GLUCAGON LIKE PEPTIDE 1; GLUCAGON RECEPTOR; GLUCOSE 6 PHOSPHATASE; INSULIN; INSULIN RECEPTOR; INTERLEUKIN 6; LEPTIN; MITOGEN ACTIVATED PROTEIN KINASE 3; NEUROPEPTIDE Y; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE 1; PROOPIOMELANOCORTIN; STAT3 PROTEIN; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR FKHR;

AMYGDALOID NUCLEUS; ARTICLE; BLOOD BRAIN BARRIER; BRAIN STEM; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; DIABETES MELLITUS; ENERGY; ENERGY EXPENDITURE; FEEDING BEHAVIOR; FOOD INTAKE; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; GLYCOGEN SYNTHESIS; HUMAN; HYPERGLUCAGONEMIA; HYPERGLYCEMIA; INFLAMMATION; INSULIN RESISTANCE; LATERAL BRAIN VENTRICLE; LIVER; MEDIOBASAL HYPOTHALAMUS; NONHUMAN; OBESITY; OVERNUTRITION; PANCREAS; PATHOGENESIS; PROTEIN EXPRESSION; RESPIRATORY QUOTIENT; SIGNAL TRANSDUCTION; THERMOGENESIS; WEIGHT CHANGE; WEIGHT GAIN;

ANIMALS; APPETITE REGULATION; BODY WEIGHT; CENTRAL NERVOUS SYSTEM; GLUCAGON; GLUCOSE; HUMANS; INSULIN; SIGNAL TRANSDUCTION;

EID: 84888198072     PISSN: 13899155     EISSN: 15732606     Source Type: Journal    
DOI: 10.1007/s11154-013-9258-4     Document Type: Article

References (131)

1. Ginter E, Simko V. Global prevalence and future of diabetes mellitus. Adv Exp Med Biol. 2012;771:35-41.
2. Berthoud HR, Lenard NR, Shin AC. Food reward, hyperphagia, and obesity. Am J Physiol Regul Integr Comp Physiol. 2011;300(6):R1266-77.
3. Campfield LA, Smith FJ. The pathogenesis of obesity. Baillieres Best Pract Res Clin Endocrinol Metab. 1999;13(1):13-30.
4. Golay A, Ybarra J. Link between obesity and type 2 diabetes. Best Pract Res Clin Endocrinol Metab. 2005;19(4):649-63.
5. Das A, Mukhopadhyay S. The evil axis of obesity, inflammation and type-2 diabetes. Endocr Metab Immune Disord Drug Targets. 2011;11(1):23-31.
6. Ahima RS, Qi Y, Singhal NS. Adipokines that link obesity and diabetes to the hypothalamus. Prog Brain Res. 2006;153:155-74.
7. Morton GJ, Cummings DE, Baskin DG, Barsh GS, Schwartz MW. Central nervous system control of food intake and body weight. Nature. 2006;443(7109):289-95.
8. Breen DM, Rasmussen BA, Kokorovic A, Wang R, Cheung GW, Lam TK. Jejunal nutrient sensing is required for duodenal-jejunal bypass surgery to rapidly lower glucose concentrations in uncontrolled diabetes. Nat Med. 2012;18(6):950-5.
9. Yue JT, Lam TK. Lipid sensing and insulin resistance in the brain. Cell Metab. 2012;15(5):646-55.
10. Lam TK. Neuronal regulation of homeostasis by nutrient sensing. Nat Med. 2010;16(4):392-5.
11. Hochberg I, Hochberg Z. Expanding the definition of hypothalamic obesity. Obes Rev. 2010;11(10):709-21.
12. Banks WA, Jaspan JB, Kastin AJ. Selective, physiological transport of insulin across the blood-brain barrier: novel demonstration by species-specific radioimmunoassays. Peptides. 1997;18(8):1257-62.
13. Inokuchi A, Oomura Y, Shimizu N, Yamamoto T. Central action of glucagon in rat hypothalamus. Am J Physiol. 1986;250(1 Pt 2):R120-6.
14. Banks WA, Kastin AJ. Peptides and the blood-brain barrier: lipophilicity as a predictor of permeability. Brain Res Bull. 1985;15(3):287-92.
15. Porte Jr D, Baskin DG, Schwartz MW. Insulin signaling in the central nervous system: a critical role in metabolic homeostasis and disease from C. elegans to humans. Diabetes. 2005;54(5):1264-76.
16. Unger JW, Moss AM, Livingston JN. Immunohistochemical localization of insulin receptors and phosphotyrosine in the brainstem of the adult rat. Neuroscience. 1991;42(3):853-61.
17. Baura GD, Foster DM, Porte Jr D, Kahn SE, Bergman RN, Cobelli C, et al. Saturable transport of insulin from plasma into the central nervous system of dogs in vivo. A mechanism for regulated insulin delivery to the brain. J Clin Invest. 1993;92(4):1824-30.
18. Woods SC, Lotter EC, McKay LD, Porte Jr D. Chronic intracerebroventricular infusion of insulin reduces food intake and body weight of baboons. Nature. 1979;282(5738):503-5.
19. McGowan MK, Andrews KM, Kelly J, Grossman SP. Effects of chronic intrahypothalamic infusion of insulin on food intake and diurnal meal patterning in the rat. Behav Neurosci. 1990;104(2):373-85.
20. Park S, Hong SM, Ahn IS. Long-term intracerebroventricular infusion of insulin, but not glucose, modulates body weight and hepatic insulin sensitivity by modifying the hypothalamic insulin signaling pathway in type 2 diabetic rats. Neuroendocrinology. 2009;89(4):387-99.
21. Clegg DJ, Riedy CA, Smith KA, Benoit SC, Woods SC. Differential sensitivity to central leptin and insulin in male and female rats. Diabetes. 2003;52(3):682-7.
22. Foster LA, Ames NK, Emery RS. Food intake and serum insulin responses to intraventricular infusions of insulin and IGF-I. Physiol Behav. 1991;50(4):745-9.
23. Brown LM, Clegg DJ, Benoit SC, Woods SC. Intraventricular insulin and leptin reduce food intake and body weight in C57BL/6J mice. Physiol Behav. 2006;89(5):687-91.
24. Zhang X, Zhang G, Zhang H, Karin M, Bai H, Cai D. Hypothalamic IKKbeta/NF-kappaB and ER stress link overnutrition to energy imbalance and obesity. Cell. 2008;135(1):61-73.
25. Shiraishi J, Yanagita K, Fukumori R, Sugino T, Fujita M, Kawakami S, et al. Comparisons of insulin related parameters in commercial-type chicks: evidence for insulin resistance in broiler chicks. Physiol Behav. 2011;103(2):233-9.
26. Hallschmid M, Benedict C, Schultes B, Fehm HL, Born J, Kern W. Intranasal insulin reduces body fat in men but not in women. Diabetes. 2004;53(11):3024-9.
27. Benedict C, Kern W, Schultes B, Born J, Hallschmid M. Differential sensitivity of men and women to anorexigenic and memory-improving effects of intranasal insulin. J Clin Endocrinol Metab. 2008;93(4):1339-44.
28. Hallschmid M, Higgs S, Thienel M, Ott V, Lehnert H. Postprandial administration of intranasal insulin intensifies satiety and reduces intake of palatable snacks in women. Diabetes. 2012;61(4):782-9.
29. Filippi BM, Mighiu PI, Lam TK. Is insulin action in the brain clinically relevant? Diabetes. 2012;61(4):773-5.
30. Varela L, Horvath TL. Leptin and insulin pathways in POMC and AgRP neurons that modulate energy balance and glucose homeostasis. EMBO Rep. 2012;13(12):1079-86.
31. Schwartz MW, Sipols AJ, Marks JL, Sanacora G, White JD, Scheurink A, et al. Inhibition of hypothalamic neuropeptide Y gene expression by insulin. Endocrinology. 1992;130(6):3608-16.
32. Benoit SC, Air EL, Coolen LM, Strauss R, Jackman A, Clegg DJ, et al. The catabolic action of insulin in the brain is mediated by melanocortins. J Neurosci. 2002;22(20):9048-52.
33. Xu AW, Kaelin CB, Takeda K, Akira S, Schwartz MW, Barsh GS. PI3K integrates the action of insulin and leptin on hypothalamic neurons. J Clin Invest. 2005;115(4):951-8.
34. Guo S, Rena G, Cichy S, He X, Cohen P, Unterman T. Phosphorylation of serine 256 by protein kinase B disrupts transactivation by FKHR and mediates effects of insulin on insulin-like growth factor-binding protein-1 promoter activity through a conserved insulin response sequence. J Biol Chem. 1999;274(24):17184-92.
35. Gan L, Zheng W, Chabot JG, Unterman TG, Quirion R. Nuclear/cytoplasmic shuttling of the transcription factor FoxO1 is regulated by neurotrophic factors. J Neurochem. 2005;93(5):1209-19.
36. Kitamura T, Feng Y, Kitamura YI, Chua Jr SC, Xu AW, Barsh GS, et al. Forkhead protein FoxO1 mediates Agrp-dependent effects of leptin on food intake. Nat Med. 2006;12(5):534-40.
37. Iskandar K, Cao Y, Hayashi Y, Nakata M, Takano E, Yada T, et al. PDK-1/FoxO1 pathway in POMC neurons regulates Pomc expression and food intake. Am J Physiol Endocrinol Metab. 2010;298(4):E787-98.
38. Cao Y, Nakata M, Okamoto S, Takano E, Yada T, Minokoshi Y, et al. PDK1-Foxo1 in agouti-related peptide neurons regulates energy homeostasis by modulating food intake and energy expenditure. PLoS One. 2011;6(4):e18324.
39. Bruning JC, Gautam D, Burks DJ, Gillette J, Schubert M, Orban PC, et al. Role of brain insulin receptor in control of body weight and reproduction. Science. 2000;289(5487):2122-5.
40. Obici S, Feng Z, Karkanias G, Baskin DG, Rossetti L. Decreasing hypothalamic insulin receptors causes hyperphagia and insulin resistance in rats. Nat Neurosci. 2002;5(6):566-72.
41. Carvalheira JB, Ribeiro EB, Araujo EP, Guimaraes RB, Telles MM, Torsoni M, et al. Selective impairment of insulin signalling in the hypothalamus of obese Zucker rats. Diabetologia. 2003;46(12):1629-40.
42. De Souza CT, Araujo EP, Bordin S, Ashimine R, Zollner RL, Boschero AC, et al. Consumption of a fat-rich diet activates a proinflammatory response and induces insulin resistance in the hypothalamus. Endocrinology. 2005;146(10):4192-9.
43. Posey KA, Clegg DJ, Printz RL, Byun J, Morton GJ, Vivekanandan-Giri A, et al. Hypothalamic proinflammatory lipid accumulation, inflammation, and insulin resistance in rats fed a high-fat diet. Am J Physiol Endocrinol Metab. 2009;296(5):E1003-12.
44. Zhang X, Dong F, Ren J, Driscoll MJ, Culver B. High dietary fat induces NADPH oxidase-associated oxidative stress and inflammation in rat cerebral cortex. Exp Neurol. 2005;191(2):318-25.
45. Parton LE, Ye CP, Coppari R, Enriori PJ, Choi B, Zhang CY, et al. Glucose sensing by POMC neurons regulates glucose homeostasis and is impaired in obesity. Nature. 2007;449(7159):228-32.
46. Hotamisligil GS. Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell. 2010;140(6):900-17.
47. Milanski M, Degasperi G, Coope A, Morari J, Denis R, Cintra DE, et al. Saturated fatty acids produce an inflammatory response predominantly through the activation of TLR4 signaling in hypothalamus: implications for the pathogenesis of obesity. J Neurosci. 2009;29(2):359-70.
48. Kleinridders A, Schenten D, Konner AC, Belgardt BF, Mauer J, Okamura T, et al. MyD88 signaling in the CNS is required for development of fatty acid-induced leptin resistance and diet-induced obesity. Cell Metab. 2009;10(4):249-59.
49. Begg DP, Mul JD, Liu M, Reedy BM, D'Alessio DA, Seeley RJ, et al. Reversal of diet-induced obesity increases insulin transport into cerebrospinal fluid and restores sensitivity to the anorexic action of central insulin in male rats. Endocrinology. 2013;154(3):1047-54.
50. Konner AC, Hess S, Tovar S, Mesaros A, Sanchez-Lasheras C, Evers N, et al. Role for insulin signaling in catecholaminergic neurons in control of energy homeostasis. Cell Metab. 2011;13(6):720-8.
51. Boghossian S, Lemmon K, Park M, York DA. High-fat diets induce a rapid loss of the insulin anorectic response in the amygdala. Am J Physiol Regul Integr Comp Physiol. 2009;297(5):R1302-11.
52. Hayes MR, Skibicka KP, Leichner TM, Guarnieri DJ, DiLeone RJ, Bence KK, et al. Endogenous leptin signaling in the caudal nucleus tractus solitarius and area postrema is required for energy balance regulation. Cell Metab. 2010;11(1):77-83.
53. Hayes MR, Leichner TM, Zhao S, Lee GS, Chowansky A, Zimmer D, et al. Intracellular signals mediating the food intake-suppressive effects of hindbrain glucagon-like peptide-1 receptor activation. Cell Metab. 2011;13(3):320-30.
54. Blouet C, Schwartz GJ. Brainstem nutrient sensing in the nucleus of the solitary tract inhibits feeding. Cell Metab. 2012;16(5):579-87.
55. Sheng G, Chang GQ, Lin JY, Yu ZX, Fang ZH, Rong J, et al. Hypothalamic huntingtin-associated protein 1 as a mediator of feeding behavior. Nat Med. 2006;12(5):526-33.
56. Niu SN, Huang ZB, Wang H, Rao XR, Kong H, Xu J, et al. Brainstem Hap1-Ahi1 is involved in insulin-mediated feeding control. FEBS Lett. 2011;585(1):85-91.
57. Baskin DG, Figlewicz DP, Woods SC, Porte Jr D, Dorsa DM. Insulin in the brain. Annu Rev Physiol. 1987;49:335-47.
58. Anika SM, Houpt TR, Houpt KA. Insulin as a satiety hormone. Physiol Behav. 1980;25(1):21-3.
59. Vanderweele DA, Haraczkiewicz E, Van Itallie TB. Elevated insulin and satiety in obese and normal-weight rats. Appetite. 1982;3(2):99-109.
60. Lovett D, Booth DA. Four effects of exogenous insulin on food intake. Q J Exp Psychol. 1970;22(3):406-19.
61. Woods SC, Stein LJ, McKay LD, Porte Jr D. Suppression of food intake by intravenous nutrients and insulin in the baboon. Am J Physiol. 1984;247(2 Pt 2):R393-401.
62. Jiang G, Zhang BB. Glucagon and regulation of glucose metabolism. Am J Physiol Endocrinol Metab. 2003;284(4):E671-8.
63. Beale E, Andreone T, Koch S, Granner M, Granner D. Insulin and glucagon regulate cytosolic phosphoenolpyruvate carboxykinase (GTP) mRNA in rat liver. Diabetes. 1984;33(4):328-32.
64. Lok S, Kuijper JL, Jelinek LJ, Kramer JM, Whitmore TE, Sprecher CA, et al. The human glucagon receptor encoding gene: structure, cDNA sequence and chromosomal localization. Gene. 1994;140(2):203-9.
65. Dunphy JL, Taylor RG, Fuller PJ. Tissue distribution of rat glucagon receptor and GLP-1 receptor gene expression. Mol Cell Endocrinol. 1998;141(1-2):179-86.
66. Hoosein NM, Gurd RS. Identification of glucagon receptors in rat brain. Proc Natl Acad Sci U S A. 1984;81(14):4368-72.
67. Graner JL, Abraira C. Glucagon in the cerebrospinal fluid. N Engl J Med. 1985;312(15):994-5.
68. Inokuchi A, Oomura Y, Nishimura H. Effect of intracerebroventricularly infused glucagon on feeding behavior. Physiol Behav. 1984;33(3):397-400.
69. Honda K, Kamisoyama H, Saito N, Kurose Y, Sugahara K, Hasegawa S. Central administration of glucagon suppresses food intake in chicks. Neurosci Lett. 2007;416(2):198-201.
70. Kurose Y, Kamisoyama H, Honda K, Azuma Y, Sugahara K, Hasegawa S, et al. Effects of central administration of glucagon on feed intake and endocrine responses in sheep. Anim Sci J. 2009;80(6):686-90.
71. Geary N, Kissileff HR, Pi-Sunyer FX, Hinton V. Individual, but not simultaneous, glucagon and cholecystokinin infusions inhibit feeding in men. Am J Physiol. 1992;262(6 Pt 2):R975-80.
72. Honda K, Kamisoyama H, Uemura T, Yanagi T, Saito N, Kurose Y, et al. The mechanism underlying the central glucagon-induced hyperglycemia and anorexia in chicks. Comp Biochem Physiol A Mol Integr Physiol. 2012;163(3-4):260-4.
73. Saito S, Tachibana T, Choi YH, Denbow DM, Furuse M. ICV CRF and isolation stress differentially enhance plasma corticosterone concentrations in layer- and meat-type neonatal chicks. Comp Biochem Physiol A Mol Integr Physiol. 2005;141(3):305-9.
74. Weisinger RS, Blair-West JR, Burns P, Denton DA, McKinley MJ, Purcell B, et al. The inhibitory effect of hormones associated with stress on Na appetite of sheep. Proc Natl Acad Sci U S A. 2000;97(6):2922-7.
75. Aou S, Oomura Y, Lenard L, Nishino H, Inokuchi A, Minami T, et al. Behavioral significance of monkey hypothalamic glucose-sensitive neurons. Brain Res. 1984;302(1):69-74.
76. Oomura Y, Ooyama H, Sugimori M, Nakamura T, Yamada Y. Glucose inhibition of the glucose-sensitive neurone in the rat lateral hypothalamus. Nature. 1974;247(439):284-6.
77. Oomura Y. Significance of glucose, insulin and free fatty acid on the hypothalamic feeding and satiety neurons. In: Novin DN, Wyrwicka W, Bray GA, editors. Hunger: basic mechanisms and clinical implications. New York: Raven; 1976. p. 145-57.
78. Parker JA, McCullough KA, Field BC, Minnion JS, Martin NM, Ghatei MA, et al. Glucagon and GLP-1 inhibit food intake and increase c-fos expression in similar appetite regulating centres in the brainstem and amygdala. Int J Obes (Lond). 2013. doi: 10.1038/ijo.2012.227.
79. Komenami N, Su FH, Thibault L. Effect of central glucagon infusion on macronutrient selection in rats. Physiol Behav. 1996;59(2):383-8.
80. Atrens DM, Menendez JA. Glucagon and the paraventricular hypothalamus: modulation of energy balance. Brain Res. 1993;630(1-2):245-51.
81. Sindelar DK, Chu CA, Venson P, Donahue EP, Neal DW, Cherrington AD. Basal hepatic glucose production is regulated by the portal vein insulin concentration. Diabetes. 1998;47(4):523-9.
82. Rebrin K, Steil GM, Mittelman SD, Bergman RN. Causal linkage between insulin suppression of lipolysis and suppression of liver glucose output in dogs. J Clin Invest. 1996;98(3):741-9.
83. Boden G, Chen X, Ruiz J, White JV, Rossetti L. Mechanisms of fatty acid-induced inhibition of glucose uptake. J Clin Invest. 1994;93(6):2438-46.
84. Lewis GF, Vranic M, Harley P, Giacca A. Fatty acids mediate the acute extrahepatic effects of insulin on hepatic glucose production in humans. Diabetes. 1997;46(7):1111-9.
85. Chowers I, Lavy S, Halpern L. Effect of insulin administered intracisternally on the glucose level of the blood and the cerebrospinal fluid in vagotomized dogs. Exp Neurol. 1966;14(3):383-9.
86. Agarwala GC, Mittal RK, Bapat SK, Bhardwaj UR. Effect of centrally administered insulin on blood glucose levels in dogs. Indian J Physiol Pharmacol. 1977;21(1):11-8.
87. Sindelar DK, Balcom JH, Chu CA, Neal DW, Cherrington AD. A comparison of the effects of selective increases in peripheral or portal insulin on hepatic glucose production in the conscious dog. Diabetes. 1996;45(11):1594-604.
88. Ramnanan CJ, Saraswathi V, Smith MS, Donahue EP, Farmer B, Farmer TD, et al. Brain insulin action augments hepatic glycogen synthesis without suppressing glucose production or gluconeogenesis in dogs. J Clin Invest. 2011;121(9):3713-23.
89. Pocai A, Lam TK, Gutierrez-Juarez R, Obici S, Schwartz GJ, Bryan J, et al. Hypothalamic K(ATP) channels control hepatic glucose production. Nature. 2005;434(7036):1026-31.
90. Obici S, Zhang BB, Karkanias G, Rossetti L. Hypothalamic insulin signaling is required for inhibition of glucose production. Nat Med. 2002;8(12):1376-82.
91. Konner AC, Janoschek R, Plum L, Jordan SD, Rother E, Ma X, et al. Insulin action in AgRP-expressing neurons is required for suppression of hepatic glucose production. Cell Metab. 2007;5(6):438-49.
92. Lin HV, Plum L, Ono H, Gutierrez-Juarez R, Shanabrough M, Borok E, et al. Divergent regulation of energy expenditure and hepatic glucose production by insulin receptor in agouti-related protein and POMC neurons. Diabetes. 2010;59(2):337-46.
93. Okamoto H, Nakae J, Kitamura T, Park BC, Dragatsis I, Accili D. Transgenic rescue of insulin receptor-deficient mice. J Clin Invest. 2004;114(2):214-23.
94. Inoue H, Ogawa W, Asakawa A, Okamoto Y, Nishizawa A, Matsumoto M, et al. Role of hepatic STAT3 in brain-insulin action on hepatic glucose production. Cell Metab. 2006;3(4):267-75.
95. Ono H, Pocai A, Wang Y, Sakoda H, Asano T, Backer JM, et al. Activation of hypothalamic S6 kinase mediates diet-induced hepatic insulin resistance in rats. J Clin Invest. 2008;118(8):2959-68.
96. Gelling RW, Morton GJ, Morrison CD, Niswender KD, Myers Jr MG, Rhodes CJ, et al. Insulin action in the brain contributes to glucose lowering during insulin treatment of diabetes. Cell Metab. 2006;3(1):67-73.
97. Purkayastha S, Zhang H, Zhang G, Ahmed Z, Wang Y, Cai D. Neural dysregulation of peripheral insulin action and blood pressure by brain endoplasmic reticulum stress. Proc Natl Acad Sci U S A. 2011;108(7):2939-44.
98. Kishore P, Boucai L, Zhang K, Li W, Koppaka S, Kehlenbrink S, et al. Activation of K(ATP) channels suppresses glucose production in humans. J Clin Invest. 2011;121(12):4916-20.
99. Filippi BM, Yang CS, Tang C, Lam TK. Insulin activates Erk1/2 signaling in the dorsal vagal complex to inhibit glucose production. Cell Metab. 2012;16(4):500-10.
100. Muller WA, Faloona GR, Aguilar-Parada E, Unger RH. Abnormal alpha-cell function in diabetes. Response to carbohydrate and protein ingestion. N Engl J Med. 1970;283(3):109-15.
101. Unger RH. Role of glucagon in the pathogenesis of diabetes: the status of the controversy. Metabolism. 1978;27(11):1691-709.
102. Aronoff SL, Bennett PH, Unger RH. Immunoreactive glucagon (IRG) responses to intravenous glucose in prediabetes and diabetes among Pima Indians and normal Caucasians. J Clin Endocrinol Metab. 1977;44(5):968-72.
103. Johnson DG, Goebel CU, Hruby VJ, Bregman MD, Trivedi D. Hyperglycemia of diabetic rats decreased by a glucagon receptor antagonist. Science. 1982;215(4536):1115-6.
104. Djuric SW, Grihalde N, Lin CW. Glucagon receptor antagonists for the treatment of type II diabetes: current prospects. Curr Opin Investig Drugs. 2002;3(11):1617-23.
105. Brand CL, Rolin B, Jorgensen PN, Svendsen I, Kristensen JS, Holst JJ. Immunoneutralization of endogenous glucagon with monoclonal glucagon antibody normalizes hyperglycaemia in moderately streptozotocin-diabetic rats. Diabetologia. 1994;37(10):985-93.
106. Liang Y, Osborne MC, Monia BP, Bhanot S, Gaarde WA, Reed C, et al. Reduction in glucagon receptor expression by an antisense oligonucleotide ameliorates diabetic syndrome in db/db mice. Diabetes. 2004;53(2):410-7.
107. Sloop KW, Cao JX, Siesky AM, Zhang HY, Bodenmiller DM, Cox AL, et al. Hepatic and glucagon-like peptide-1-mediated reversal of diabetes by glucagon receptor antisense oligonucleotide inhibitors. J Clin Invest. 2004;113(11):1571-81.
108. Lee Y, Wang MY, Du XQ, Charron MJ, Unger RH. Glucagon receptor knockout prevents insulin-deficient type 1 diabetes in mice. Diabetes. 2011;60(2):391-7.
109. Eigler N, Sacca L, Sherwin RS. Synergistic interactions of physiologic increments of glucagon, epinephrine, and cortisol in the dog: a model for stress-induced hyperglycemia. J Clin Invest. 1979;63(1):114-23.
110. Bomboy Jr JD, Lewis SB, Lacy WW, Sinclair-Smith BC, Liljenquist JE. Transient stimulatory effect of sustained hyperglucagonemia on splanchnic glucose production in normal and diabetic man. Diabetes. 1977;26(3):177-84.
111. Felig P, Wahren J, Hendler R. Influence of physiologic hyperglucagonemia on basal and insulin-inhibited splanchnic glucose output in normal man. J Clin Invest. 1976;58(3):761-5.
112. Ferrannini E, DeFronzo RA, Sherwin RS. Transient hepatic response to glucagon in man: role of insulin and hyperglycemia. Am J Physiol. 1982;242(2):E73-81.
113. Cherrington AD, Lacy WW, Chiasson JL. Effect of glucagon on glucose production during insulin deficiency in the dog. J Clin Invest. 1978;62(3):664-77.
114. German J, Kim F, Schwartz GJ, Havel PJ, Rhodes CJ, Schwartz MW, et al. Hypothalamic leptin signaling regulates hepatic insulin sensitivity via a neurocircuit involving the vagus nerve. Endocrinology. 2009;150(10):4502-11.
115. Buettner C, Pocai A, Muse ED, Etgen AM, Myers Jr MG, Rossetti L. Critical role of STAT3 in leptin's metabolic actions. Cell Metab. 2006;4(1):49-60.
116. Sandoval DA, Bagnol D, Woods SC, D'Alessio DA, Seeley RJ. Arcuate glucagon-like peptide 1 receptors regulate glucose homeostasis but not food intake. Diabetes. 2008;57(8):2046-54.
117. Muse ED, Lam TK, Scherer PE, Rossetti L. Hypothalamic resistin induces hepatic insulin resistance. J Clin Invest. 2007;117(6):1670-8.
118. Agarwala GC, Bapat SK. Effect of centrally administered glucagon on blood glucose levels in dogs. Indian J Med Res. 1977;66(2):323-30.
119. Marubashi S, Tominaga M, Katagiri T, Yamatani K, Yawata Y, Hara M, et al. Hyperglycaemic effect of glucagon administered intracerebroventricularly in the rat. Acta Endocrinol (Copenh). 1985;108(1):6-10.
120. Ruiter M, la Fleur SE, Van Heijningen C, van der Vliet J, Kalsbeek A, Buijs RM. The daily rhythm in plasma glucagon concentrations in the rat is modulated by the biological clock and by feeding behavior. Diabetes. 2003;52(7):1709-15.
121. Amir S. Central glucagon-induced hyperglycemia is mediated by combined activation of the adrenal medulla and sympathetic nerve endings. Physiol Behav. 1986;37(4):563-6.
122. Agarwala GC, Mishra R, Jaiswal G, Bapat V. Effect of centrally administered glucagon on liver glycogen & enzymes in anaesthetised dogs. Indian J Med Res. 1989;90:372-8.
123. Menendez JA, Atrens DM. Insulin and the paraventricular hypothalamus: modulation of energy balance. Brain Res. 1991;555(2):193-201.
124. Yue JT, Mighiu PI, Naples M, Adeli K, Lam TK. Glycine normalizes hepatic triglyceride-rich VLDL secretion by triggering the CNS in high-fat fed rats. Circ Res. 2012;110(10):1345-54.
125. Buettner C, Muse ED, Cheng A, Chen L, Scherer T, Pocai A, et al. Leptin controls adipose tissue lipogenesis via central, STAT3-independent mechanisms. Nat Med. 2008;14(6):667-75.
126. Koch L, Wunderlich FT, Seibler J, Konner AC, Hampel B, Irlenbusch S, et al. Central insulin action regulates peripheral glucose and fat metabolism in mice. J Clin Invest. 2008;118(6):2132-47.
127. Nogueiras R, Wiedmer P, Perez-Tilve D, Veyrat-Durebex C, Keogh JM, Sutton GM, et al. The central melanocortin system directly controls peripheral lipid metabolism. J Clin Invest. 2007;117(11):3475-88.
128. Perez-Tilve D, Hofmann SM, Basford J, Nogueiras R, Pfluger PT, Patterson JT, et al. Melanocortin signaling in the CNS directly regulates circulating cholesterol. Nat Neurosci. 2010;13(7):877-82.
129. Stafford JM, Yu F, Printz R, Hasty AH, Swift LL, Niswender KD. Central nervous system neuropeptide Y signaling modulates VLDL triglyceride secretion. Diabetes. 2008;57(6):1482-90.
130. Theander-Carrillo C, Wiedmer P, Cettour-Rose P, Nogueiras R, Perez-Tilve D, Pfluger P, et al. Ghrelin action in the brain controls adipocyte metabolism. J Clin Invest. 2006;116(7):1983-93.
131. van den Hoek AM, Voshol PJ, Karnekamp BN, Buijs RM, Romijn JA, Havekes LM, et al. Intracerebroventricular neuropeptide Y infusion precludes inhibition of glucose and VLDL production by insulin. Diabetes. 2004;53(10):2529-34.